Peter Mu‐Hsin Chang

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri et al. · The Lancet Oncology · 2021 · 617 citations

Medicine, Oncology, Radiation Oncology +8

Treatment for T1-2 Oral Squamous Cell Carcinoma with or Without Perineural Invasion: Neck Dissection and Postoperative Adjuvant Therapy

Shyh‐Kuan Tai, Wing–Yin Li, Muh‐Hwa Yang et al. · Annals of Surgical Oncology · 2011 · 89 citations

Medicine, Neck Surgery, Oncology +13

Identification of Withaferin A as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer

Jade H.-M. Hsu, Peter Mu‐Hsin Chang, Tai-Shan Cheng et al. · Cancers · 2019 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

<i>ERCC1</i> codon 118 C→T polymorphism associated with <i>ERCC1</i> expression and outcome of FOLFOX‐4 treatment in Asian patients with metastatic colorectal carcinoma

Peter Mu‐Hsin Chang, Cheng‐Hwai Tzeng, Po‐Min Chen et al. · Cancer Science · 2008 · 66 citations · Full text

Medicine, Genetics, Oncology +15

Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis

Hong Li, Chi‐Ling Chiang, Kwang Joo Kwak et al. · Advanced Science · 2024 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +17